Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

562

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

May 2, 2022

Study Completion Date

December 6, 2022

Conditions
Cystic FibrosisContraception
Trial Locations (10)

10003

Mount Sinai Beth Israel, New York

15260

University of Pittsburgh, Pittsburgh

19104

University of Pennsylvania, Philadelphia

21218

Johns Hopkins University, Baltimore

35294

University of Alabama at Birmingham, Birmingham

75390

University of Texas Southwestern, Dallas

80206

National Jewish Health, Denver

92093

University of California - San Diego, San Diego

98105

University of Washington, Seattle

02115

Boston Children's Hospital/Harvard, Boston

All Listed Sponsors
lead

University of Washington

OTHER

NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis | Biotech Hunter | Biotech Hunter